Beacon Pointe Advisors, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1744317
NEWPORT BEACH, CA
Position in REGN
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$12,134,088
-$2,901,486 QoQ
Shares Held
19,460
0.0% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#269
of 1,322 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Beacon Pointe Advisors, LLC holds $41,283,927 across 27 Biotechnology names. REGN ranks #1 (29.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
19,460 | $12,134,088 | |
| 2 | INCY |
Incyte Corp
|
84,502 | $9,579,146 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
17,047 | $8,467,756 | |
| 4 | NUVB |
Nuvation Bio Inc.
|
632,251 | $3,591,185 | |
| 5 | SMMT |
Summit Therapeutics Inc.
|
98,114 | $1,429,520 | |
| 6 | BNTX |
BioNTech SE
|
13,199 | $1,228,166 | |
| 7 | IBRX |
ImmunityBio, Inc.
|
73,497 | $643,466 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
11,307 | $616,683 |
All Filings in REGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,134,088 | 19,460 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $15,035,574 | 19,460 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,311,839 | 12,064 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $6,865,878 | 12,211 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,220,175 | 19,467 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $12,376,998 | 19,515 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $14,015,805 | 19,676 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $21,130,975 | 20,101 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $23,406,438 | 22,270 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $21,752,274 | 22,600 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $20,012,715 | 22,786 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $19,611,959 | 23,831 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $16,218,884 | 22,572 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $20,360,160 | 24,779 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $23,032,125 | 31,923 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $19,090,654 | 27,713 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $16,581,787 | 28,051 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $19,939,891 | 28,550 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $15,754,529 | 24,947 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $17,581,084 | 29,051 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,995,236 | 7,153 | Shares | Sole | 2021-08-17 | |
| No filing history on record for this holder in this stock. | ||||||